Radioligand Therapy With Lu-177-Prostate-Specific Membrane Antigen in a Patient With Non-Prostate-Specific Antigen-Secreting Metastatic Prostate Cancer

Pirayesh Elahe

首页> 外文期刊>Clinical nuclear medicine >Radioligand Therapy With Lu-177-Prostate-Specific Membrane Antigen in a Patient With Non-Prostate-Specific Antigen-Secreting Metastatic Prostate Cancer

【24h】

Radioligand Therapy With Lu-177-Prostate-Specific Membrane Antigen in a Patient With Non-Prostate-Specific Antigen-Secreting Metastatic Prostate Cancer

机译：用非前列腺特异性抗原分泌转移性前列腺癌患者的Lu-177-前列腺特异性膜抗原的放射性末端治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Clinical nuclear medicine》 |2020年第10期|共3页
作者
Pirayesh Elahe;
展开▼
作者单位

Shahid Beheshti Univ Med Sci Sch Med Shohadae Tajrish Med Ctr Dept Nucl Med Tehran Iran;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
Lu-177-PSMA; prostate cancer; prostate-specific antigen; radioligand therapy;

机译：lu-177-psma;前列腺癌;前列腺特异性抗原;放射性配体疗法;

相似文献

外文文献
中文文献
专利

1. Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy [J] . Jeremy YC Teoh, James HL Tsu, Steffi KK Yuen, 亚洲男性学杂志（英文版） . 2017,第001期
2. The emerging role of prostate-specific membrane antigen(PSMA)PET-CT in patients with high-risk prostate cancer:moving the bar in high-risk prostate cancer [J] . Jeanny B Aragon-Ching 亚洲男性学杂志（英文版） . 2021,第001期
3. Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient [J] . Marwan Ghosn, Alain Dagher, Fadi El-Karak 生物医学研究杂志（英文版） . 2015,第005期
4. Prostate-specific antigen doubling in a hormone-resistant metastatic time and response to cabazitaxel prostate cancer patient [J] . Marwan, Ghosn, Alain, 生物医学研究杂志：英文版 . 2015,第005期
5. Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with Lu-177-labeled prostate-specific membrane antigen [J] . Huang Kai, Schatka Imke, Rogasch Julian M. M., Annals of nuclear medicine . 2021,第3期

机译：探讨分解评分，预测转移性，抵抗前列腺癌患者接受放射性腺素疗法的患者治疗，Lu-177标记的前列腺特异性膜抗原
6. Systemic Radioligand Therapy with Lu-177 Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer EDITORIAL COMMENT [J] . Sanchez-Salas Rafael The Journal of Urology . 2016,第2期

机译：Lu-177标记的前列腺特异性膜抗原配体的全身放射配体疗法用于转移性去势抵抗性前列腺癌患者的影像学和治疗
7. Systemic Radioligand Therapy with Lu-177 Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer EDITORIAL COMMENT [J] . Iagaru Andrei The Journal of Urology . 2016,第2期

机译：Lu-177标记的前列腺特异性膜抗原配体的全身放射配体疗法用于转移性去势抵抗性前列腺癌患者的影像学和治疗
8. Identification of Circulating Pluripotent Cancer Stem Cells in the Blood of Prostate Cancer Patients for the Diagnosis of Metastatic Cancer [C] . Anette Claudia Schafer, Yawen Ju, Youngbin Tak, International Molecular Medicine Tri-Conference. . 2016

机译：鉴定前列腺癌患者血液中循环多能癌症干细胞诊断转移性癌症
9. The Role of Prostate Specific Membrane Antigen in Prostate Cancer and Pathologic Angiogenesis in Vivo [D] . Grant, Christina Lee. 2012

机译：前列腺特异性膜抗原在前列腺癌和体内病理性血管生成中的作用
10. Efficacy and Haematologic Toxicity of Palliative Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen in Heavily Pre-Treated Patients [O] . Murali Kesavan, Danielle Meyrick, Marat Gallyamov, 2021

机译：在大量预处理的患者中尿液溶胀前列腺癌尿液溶胀前列腺癌治疗的疗效和血吸虫学毒性疗效和血吸虫学毒性
11. Efficacy and Haematologic Toxicity of Palliative Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen in Heavily Pre-Treated Patients [O] . Murali Kesavan, Danielle Meyrick, Marat Gallyamov, 2021

机译：在大量预处理的患者中，尿液溶胀前列腺癌尿液溶胀前列腺癌治疗的疗效和血吸虫学毒性疗效和血吸虫学毒性尿液中的抑制剂 - 177-标记的前列腺特异性膜抗原
12. Prostate Specific Membrane Antigen (PSMA) Targeted Bio-orthogonal Therapy for Metastatic Prostate Cancer. [R] . Artemov, D. 2017

机译：前列腺特异性膜抗原（psma）靶向生物正交治疗转移性前列腺癌。

Radioligand Therapy With Lu-177-Prostate-Specific Membrane Antigen in a Patient With Non-Prostate-Specific Antigen-Secreting Metastatic Prostate Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅